{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:04:20Z","timestamp":1790615060414,"version":"4.1.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221482","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T17:49:53Z","timestamp":1566409793000},"page":"e0221482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6531-9018","authenticated-orcid":true,"given":"Yuji","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"issue":"5","key":"pone.0221482.ref001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1601-183X.2009.00509.x","article-title":"Szt2, a novel gene for seizure threshold in mice","volume":"8","author":"WN Frankel","year":"2009","journal-title":"Genes Brain Behav"},{"issue":"4","key":"pone.0221482.ref002","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cge.13135","article-title":"mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review","volume":"93","author":"G Gordo","year":"2018","journal-title":"Clinical genetics"},{"issue":"8","key":"pone.0221482.ref003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.braindev.2018.04.008","article-title":"Distinctive facies, macrocephaly, and developmental delay are signs of a PTEN mutation in childhood","volume":"40","author":"K Kato","year":"2018","journal-title":"Brain Dev"},{"issue":"1","key":"pone.0221482.ref004","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-016-0363-6","article-title":"A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly","volume":"18","author":"Y Negishi","year":"2017","journal-title":"BMC Medical Genetics"},{"issue":"3","key":"pone.0221482.ref005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ajmg.c.31651","article-title":"Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice","volume":"178","author":"A Peron","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"8","key":"pone.0221482.ref006","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng.2331","article-title":"De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes","volume":"44","author":"J-B Rivi\u00e8re","year":"2012","journal-title":"Nature Genetics"},{"issue":"3","key":"pone.0221482.ref007","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajhg.2013.07.005","article-title":"Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum","volume":"93","author":"L Basel-Vanagaite","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"12","key":"pone.0221482.ref008","doi-asserted-by":"crossref","first-page":"e82810","DOI":"10.1371\/journal.pone.0082810","article-title":"An amino acid deletion inSZT2 in a family with non-syndromic intellectual disability","volume":"8","author":"M Falcone","year":"2013","journal-title":"PLoS One"},{"key":"pone.0221482.ref009","article-title":"SZT2 mutation in a boy with intellectual disability, seizures and autistic features","author":"A Kariminejad","year":"2018","journal-title":"Eur J Med Genet"},{"issue":"2","key":"pone.0221482.ref010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.braindev.2017.08.003","article-title":"Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum","volume":"40","author":"Y Nakamura","year":"2018","journal-title":"Brain Dev"},{"issue":"11","key":"pone.0221482.ref011","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s13258-018-0673-5","article-title":"A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy","volume":"40","author":"MI Naseer","year":"2018","journal-title":"Genes Genomics"},{"issue":"6","key":"pone.0221482.ref012","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/ajmg.a.38717","article-title":"Mutations in SZT2 result in early-onset epileptic encephalopathy and leukoencephalopathy","volume":"176","author":"A Pizzino","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"2","key":"pone.0221482.ref013","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cge.13061","article-title":"Novel biallelic SZT2 mutations in 3 cases of early-onset epileptic encephalopathy","volume":"93","author":"N Tsuchida","year":"2018","journal-title":"Clinical genetics"},{"issue":"6","key":"pone.0221482.ref014","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ana.24650","article-title":"Whole exome sequencing in patients with white matter abnormalities","volume":"79","author":"A Vanderver","year":"2016","journal-title":"Annals of neurology"},{"issue":"2","key":"pone.0221482.ref015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1684\/epd.2016.0828","article-title":"Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants","volume":"18","author":"C Venkatesan","year":"2016","journal-title":"Epileptic disorders: international epilepsy journal with videotape"},{"issue":"7645","key":"pone.0221482.ref016","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature21378","article-title":"SZT2 dictates GATOR control of mTORC1 signalling","volume":"543","author":"M Peng","year":"2017","journal-title":"Nature"},{"issue":"7645","key":"pone.0221482.ref017","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature21423","article-title":"KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1","volume":"543","author":"RL Wolfson","year":"2017","journal-title":"Nature"},{"issue":"1","key":"pone.0221482.ref018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","article-title":"The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway","volume":"165","author":"L Chantranupong","year":"2016","journal-title":"Cell"},{"issue":"6268","key":"pone.0221482.ref019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"RL Wolfson","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"6","key":"pone.0221482.ref020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"RA Saxton","year":"2017","journal-title":"Cell"},{"issue":"2","key":"pone.0221482.ref021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"M Laplante","year":"2012","journal-title":"Cell"},{"issue":"4","key":"pone.0221482.ref022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00279094","article-title":"A routine method for the establishment of permanent growing lymphoblastoid cell lines","volume":"73","author":"H. Neitzel","year":"1986","journal-title":"Human genetics"},{"issue":"2","key":"pone.0221482.ref023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Y Sancak","year":"2010","journal-title":"Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T05:00:50Z","timestamp":1610859650000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221482"}},"subtitle":[],"editor":[{"given":"Andreas R.","family":"Janecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221482","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]}}}